Extracellular vesicle impact on immunity following blood transfusion
(2025) In Current Opinion in Immunology 95.- Abstract
Purpose of the Review: Recent insights into extracellular vesicles (EVs) derived from platelet (PC) and red blood cell concentrates (RBC), which form during blood product processing and storage. Recent Findings: EVs impact transfusion outcomes by modulating immune and inflammatory responses. Acting as lipid mediators and expressing adhesion molecules, EVs contribute to immune signaling via cytokines, DAMPs, and antigen-presenting molecules. In RBC, EVs accumulate during storage and are linked to endothelial cell (EC) activation, increased thrombotic risk, and tissue inflammation — especially under existing inflammatory conditions. While their effect on circulating immune cells is limited, they strongly activate tissue-resident immune... (More)
Purpose of the Review: Recent insights into extracellular vesicles (EVs) derived from platelet (PC) and red blood cell concentrates (RBC), which form during blood product processing and storage. Recent Findings: EVs impact transfusion outcomes by modulating immune and inflammatory responses. Acting as lipid mediators and expressing adhesion molecules, EVs contribute to immune signaling via cytokines, DAMPs, and antigen-presenting molecules. In RBC, EVs accumulate during storage and are linked to endothelial cell (EC) activation, increased thrombotic risk, and tissue inflammation — especially under existing inflammatory conditions. While their effect on circulating immune cells is limited, they strongly activate tissue-resident immune and EC. In PCs, platelet-derived EVs and other cell-specific EVs also emerge. Certain EV subtypes express CD27, CD70, CD39, and HLA antigens, altering T-cell, B-cell, and monocyte activity. These immunomodulatory effects may contribute to transfusion-related immunomodulation and alloimmunization. EVs in stored blood products influence immune responses highlighting the need for monitoring.
(Less)
- author
- Marcoux, Genevieve
LU
; Hasse, Stephan
LU
; Olsson, Martin L.
LU
; Egesten, Arne
LU
and Duchez, Anne Claire
- organization
-
- Respiratory Medicine, Allergology, and Palliative Medicine
- Infect@LU
- Division of Transfusion Medicine
- Transfusion Medicine (research group)
- Division of Hematology and Clinical Immunology
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- EpiHealth: Epidemiology for Health
- Novel strategies targeting detrimental airway inflammation (research group)
- Hereditary angioedema (HAE) – epidemiology, genetics and pathophysiology (research group)
- publishing date
- 2025-08
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Current Opinion in Immunology
- volume
- 95
- article number
- 102603
- publisher
- Elsevier
- external identifiers
-
- pmid:40609228
- scopus:105009515959
- ISSN
- 0952-7915
- DOI
- 10.1016/j.coi.2025.102603
- language
- English
- LU publication?
- yes
- id
- 1e31d7c8-566f-42f3-ac2f-8d6524a641d0
- date added to LUP
- 2025-11-05 09:55:49
- date last changed
- 2025-11-06 02:55:05
@article{1e31d7c8-566f-42f3-ac2f-8d6524a641d0,
abstract = {{<p>Purpose of the Review: Recent insights into extracellular vesicles (EVs) derived from platelet (PC) and red blood cell concentrates (RBC), which form during blood product processing and storage. Recent Findings: EVs impact transfusion outcomes by modulating immune and inflammatory responses. Acting as lipid mediators and expressing adhesion molecules, EVs contribute to immune signaling via cytokines, DAMPs, and antigen-presenting molecules. In RBC, EVs accumulate during storage and are linked to endothelial cell (EC) activation, increased thrombotic risk, and tissue inflammation — especially under existing inflammatory conditions. While their effect on circulating immune cells is limited, they strongly activate tissue-resident immune and EC. In PCs, platelet-derived EVs and other cell-specific EVs also emerge. Certain EV subtypes express CD27, CD70, CD39, and HLA antigens, altering T-cell, B-cell, and monocyte activity. These immunomodulatory effects may contribute to transfusion-related immunomodulation and alloimmunization. EVs in stored blood products influence immune responses highlighting the need for monitoring.</p>}},
author = {{Marcoux, Genevieve and Hasse, Stephan and Olsson, Martin L. and Egesten, Arne and Duchez, Anne Claire}},
issn = {{0952-7915}},
language = {{eng}},
publisher = {{Elsevier}},
series = {{Current Opinion in Immunology}},
title = {{Extracellular vesicle impact on immunity following blood transfusion}},
url = {{http://dx.doi.org/10.1016/j.coi.2025.102603}},
doi = {{10.1016/j.coi.2025.102603}},
volume = {{95}},
year = {{2025}},
}